Format

Send to

Choose Destination
Trends Pharmacol Sci. 2019 Jun 3. pii: S0165-6147(19)30091-4. doi: 10.1016/j.tips.2019.04.014. [Epub ahead of print]

Predicting and Understanding the Human Microbiome's Impact on Pharmacology.

Author information

1
Department of Systems and Computational Biology, Albert Einstein College of Medicine, The Bronx, NY, USA.
2
Department of Systems and Computational Biology, Albert Einstein College of Medicine, The Bronx, NY, USA; Department of Microbiology and Immunology, Albert Einstein College of Medicine, The Bronx, NY, USA. Electronic address: libusha.kelly@einstein.yu.edu.

Abstract

Our bodies each possess a unique and dynamic collection of microbes and viruses, collectively the 'microbiome', with distinct metabolic capacities from our human cells. Unforeseen modification of drugs by the microbiome can drastically alter their clinical effectiveness, with the most dramatic cases leading to fatal drug interactions. Pharmaceuticals can be activated, deactivated, toxified, or release metabolites that alter the 'canonical' pharmacokinetics of the drug. Thus, predicting and characterizing microbe-drug interactions is necessary to develop and implement personalized drug administration protocols and, more broadly, to improve drug safety and efficacy. In this review, we focus on microbiome-driven alterations to drug pharmacokinetics and provide a research framework for pharmacologists interested in characterizing microbiome interactions with any drug of interest.

KEYWORDS:

microbiome; pharmacodynamics; pharmacology; xenobiotics

PMID:
31171383
DOI:
10.1016/j.tips.2019.04.014

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center